22 results on '"Archer, D."'
Search Results
2. Safety and efficacy results for the segesterone acetate ethinyl estradiol (SA/EE) contraceptive vaginal ring
3. A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring
4. Effects of meloxicam, a semi-selective cyclo-oxygenase 2 (COX-2) inhibitor, on the ultrasound appearance of the dominant follicle before and after the luteinizing hormone (LH) surge
5. Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm
6. Contraceptive efficacy, safety and acceptability of SILCS, a novel single-sized diaphragm used with contraceptive gel
7. Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study
8. Evaluation of human spermatozoa in cervical mucus: comparison of different microscopic and extraction techniques
9. A Phase I Comparative Study of Contraceptive Vaginal Films Containing Benzalkonium Chloride and Nonoxynol-9: Postcoital Testing and Colposcopy
10. A Phase I Comparative Study of Three Contraceptive Vaginal Films Containing Nonoxynol-9: Postcoital Testing and Colposcopy
11. An Evaluation of the Amount of Nonoxynol-9 Remaining in the Vagina Up to 4 h After Insertion of a Vaginal Contraceptive Film (VCF[R]) Containing 70 mg Nonoxynol-9
12. A Phase I Study of Femcap[R] Used With and Without Spermicide: Postcoital Testing
13. A New Low-Dose Monophasic Combination Oral Contraceptive (Alesse[TM]) with Levonorgestrel 100 g and Ethinyl Estradiol 20 g
14. Lea's Shield[R]: A Study of the Safety and Efficacy of a New Vaginal Barrier Contraceptive Used With and Without Spermicide
15. Lea's Shield[R]: A Phase I Postcoital Study of a New Contraceptive Barrier Device
16. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
17. Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.
18. Safety of single daily use for one week of C31G HEC gel in women.
19. Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval.
20. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
21. Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. A possible mechanism of action of the intrauterine device.
22. A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.